These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27787359)

  • 41. Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.
    Leung RC; Liu SS; Chan KY; Tam KF; Chan KL; Wong LC; Ngan HY
    Oncol Rep; 2008 May; 19(5):1339-45. PubMed ID: 18425396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
    Hu G; Qin L; Zhang X; Ye G; Huang T
    Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
    Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
    Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
    Zhang S; Kong WJ
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
    Brabender J; Arbab D; Huan X; Vallböhmer D; Grimminger P; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
    Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
    Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
    Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methylation of DAPK and THBS1 genes in esophageal gastric-type columnar metaplasia.
    Herrera-Goepfert R; Oñate-Ocaña LF; Mosqueda-Vargas JL; Herrera LA; Castro C; Mendoza J; González-Barrios R
    World J Gastroenterol; 2016 May; 22(18):4567-75. PubMed ID: 27182166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Promoter hypermethylation of Death-associated protein-kinase gene associated with advance stage gastric cancer.
    Chan AW; Chan MW; Lee TL; Ng EK; Leung WK; Lau JY; Tong JH; Chan FK; To KF
    Oncol Rep; 2005 May; 13(5):937-41. PubMed ID: 15809761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion.
    Katayama H; Hiraki A; Aoe K; Fujiwara K; Matsuo K; Maeda T; Murakami T; Toyooka S; Sugi K; Ueoka H; Tanimoto M
    Int J Cancer; 2007 May; 120(10):2191-5. PubMed ID: 17285579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
    Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
    Chen WT; Hung WC; Kang WY; Huang YC; Chai CY
    Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of DAPK1 methylation and the risk of gastrointestinal cancer: A systematic review and meta-analysis.
    Yuan W; Chen J; Shu Y; Liu S; Wu L; Ji J; Liu Z; Tang Q; Zhou Z; Cheng Y; Jiang B; Shu X
    PLoS One; 2017; 12(9):e0184959. PubMed ID: 28934284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential hypermethylation of death-associated protein kinase promoter in central neurocytoma and oligodendroglioma.
    Chung CL; Tsai HP; Tsai CY; Chen WT; Lieu AS; Wang CJ; Sheehan J; Chai CY; Kwan AL
    Biomed Res Int; 2014; 2014():506458. PubMed ID: 24877104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological significance of DAPK promoter methylation in non-small-cell lung cancer: a systematic review and meta-analysis.
    Zhang Y; Wu J; Huang G; Xu S
    Cancer Manag Res; 2018; 10():6897-6904. PubMed ID: 30588095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa.
    Arisawa T; Tahara T; Tsutsumi M; Shibata T
    BMC Med Genet; 2012 Jul; 13():59. PubMed ID: 22827846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Detection of methylation levels of multi-genes by real-time PCR in patients with myelodysplastic syndrome].
    Wang YC; DU X; Geng SX; Li YY; Weng JY; Lu ZS; Zhong LY; Deng CX; Lai PL; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):254-8. PubMed ID: 21569709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer.
    Hu S; Liu D; Tufano RP; Carson KA; Rosenbaum E; Cohen Y; Holt EH; Kiseljak-Vassiliades K; Rhoden KJ; Tolaney S; Condouris S; Tallini G; Westra WH; Umbricht CB; Zeiger MA; Califano JA; Vasko V; Xing M
    Int J Cancer; 2006 Nov; 119(10):2322-9. PubMed ID: 16858683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.